Lupifil P 6mg Injection: Effective Solution for Your Needs

Description:

• Contains the active ingredient Pegfilgrastim.
• Belongs to the class of granulocyte colony-stimulated factor.
• Approved by the FDA to decrease the risk of developing febrile neutropenia and the duration of neutropenia when receiving bone marrow-suppressive chemotherapy drugs.
• Indicated to increase survival rate in patients exposed to radiation therapy.

Uses:

• Decreases the chance of infection caused by low levels of white blood cells in patients with certain types of cancer receiving bone marrow-suppressing anti-cancer drugs.
• Increases the survival rate in patients receiving radiation therapy that suppresses bone marrow activity.

Therapeutic Effects:

• Acts on blood-forming cells, stimulating cell multiplication and cell function activation.

Interaction with Other Drugs:

• Inform your healthcare provider about all the medicines you take.
• Certain medications may interact with Lupifil P 6mg Injection and reduce effectiveness or cause undesirable side effects.

Storage:

• Store in a refrigerator (2°C – 8°C). Do not freeze.
• Do not shake the Injection.
• Discard the Injection if it has been stored at room temperature for more than 48 hours.
• Keep out of reach from children and pets.

Administration:

• Administered subcutaneously by a qualified healthcare professional in a hospital setting.
• Dose and frequency decided by the doctor based on disease condition and other factors.
• If administered at home, follow instructions carefully from the package insert.

Safety Advices:

• Pregnancy: unsafe during pregnancy, may cause birth defects.
• Breastfeeding: unsafe to breastfeed during treatment.
• Lungs: consult doctor if you have lung problems.
• Liver: consult doctor if you have liver problems.
• Alcohol: unsafe to consume alcohol with Lupifil P 6mg Injection.
• Driving: unsafe to travel, drive vehicles, or operate heavy machinery after taking the Injection.

Side Effects:

• Common: pain in bones, joints, and muscles; pain at the site of Injection; itchiness and skin rash; nausea; headaches; dizziness and tiredness.
• Serious: inflammation of aorta; capillary leak syndrome; hypersensitivity reactions; changes in urine color; swelling in hands, feet, face, and abdomen; difficulty in breathing; sickle cell anemia.

FAQs:

• Q 1. What is the difference between Lupifil P 6mg Injection pre-filled syringe and on-body injector? The on-body injector is a small, lightweight delivery system applied to the skin during chemo appointment. It is automatically designed to inject the dose subcutaneously. The pre-filled syringe contains the medicine and should be injected by healthcare provider or manually.

• Q 2. What are the symptoms that I should notify the physician when taking Lupifil P 6mg Injection? Inform your physician if you are experiencing swelling in the face, feet, hands, and abdomen, difficulty in breathing, sudden drop in blood pressure, left abdominal pain, weakness, and skin rashes.

• Q 3. What is the Lupifil P 6mg Injection package insert? The FDA provides a package insert summarizing relevant scientific information needed for safe and effective use. It contains safety information, instructions for use, and other information.

• Q 4. Who should not take Lupifil P 6mg Injection? Do not take this Injection if you are allergic to pegfilgrastim, filgrastim, or any other ingredients in the Injection.

• Q 5. Will Lupifil P 6mg Injection affect my kidneys? This Injection may affect your kidneys. Regular kidney function tests will be taken to monitor your kidney functions.

• Q 6. Can I breastfeed while taking Lupifil P 6mg Injection? No, this Injection secretes in small amounts in breast milk. It can cause harm to your baby. Please consult your doctor if you are breastfeeding.

Fact Box:

• Molecule name: Pegfilgrastim
• Therapeutic class: Hematopoietic
• Pharmacological class: Colony-stimulating factors
• Indications: Febrile neutropenia

टैग्स: medical-injection, lupifil-p, pharmaceuticals, 6mg, drug-injection